TAS2R13
gene geneOn this page
Also known as T2R13TRB3
Summary
TAS2R13 (taste 2 receptor member 13, HGNC:14919) is a protein-coding gene on chromosome 12p13, encoding Taste receptor type 2 member 13 (Q9NYV9). Receptor that may play a role in the perception of bitterness and is gustducin-linked.
This gene product belongs to the family of candidate taste receptors that are members of the G-protein-coupled receptor superfamily. These proteins are specifically expressed in the taste receptor cells of the tongue and palate epithelia. They are organized in the genome in clusters and are genetically linked to loci that influence bitter perception in mice and humans. In functional expression studies, they respond to bitter tastants. This gene maps to the taste receptor gene cluster on chromosome 12p13.
Source: NCBI Gene 50838 — RefSeq curated summary.
At a glance
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_023920
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14919 |
| Approved symbol | TAS2R13 |
| Name | taste 2 receptor member 13 |
| Location | 12p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | T2R13, TRB3 |
| Ensembl gene | ENSG00000212128 |
| Ensembl biotype | protein_coding |
| OMIM | 604792 |
| Entrez | 50838 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000390677
RefSeq mRNA: 1 — MANE Select: NM_023920
NM_023920
CCDS: CCDS8635
Canonical transcript exons
ENST00000390677 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001508595 | 10907926 | 10909562 |
Expression profiles
Bgee: expression breadth broad, 27 present calls, max score 94.40.
Top tissues by expression
92 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.40 | gold quality |
| corpus callosum | UBERON:0002336 | 73.92 | gold quality |
| adrenal tissue | UBERON:0018303 | 66.62 | gold quality |
| calcaneal tendon | UBERON:0003701 | 64.03 | gold quality |
| bone marrow cell | CL:0002092 | 62.10 | silver quality |
| colonic epithelium | UBERON:0000397 | 57.40 | gold quality |
| sural nerve | UBERON:0015488 | 48.78 | silver quality |
| tonsil | UBERON:0002372 | 47.54 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 45.59 | silver quality |
| ventricular zone | UBERON:0003053 | 44.16 | silver quality |
| granulocyte | CL:0000094 | 41.68 | silver quality |
| muscle tissue | UBERON:0002385 | 41.20 | silver quality |
| urinary bladder | UBERON:0001255 | 40.90 | silver quality |
| liver | UBERON:0002107 | 40.85 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 39.25 | gold quality |
| adrenal gland | UBERON:0002369 | 38.06 | gold quality |
| primary visual cortex | UBERON:0002436 | 37.49 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.40 | gold quality |
| kidney | UBERON:0002113 | 36.95 | gold quality |
| endometrium | UBERON:0001295 | 36.69 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| apex of heart | UBERON:0002098 | 35.94 | gold quality |
| stomach | UBERON:0000945 | 34.78 | gold quality |
| mucosa of stomach | UBERON:0001199 | 34.74 | gold quality |
| leukocyte | CL:0000738 | 34.51 | gold quality |
| monocyte | CL:0000576 | 34.39 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 34.27 | gold quality |
| heart | UBERON:0000948 | 34.14 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 33.94 | gold quality |
| cerebellum | UBERON:0002037 | 33.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): DDIT3
miRNA regulators (miRDB)
19 targeting TAS2R13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-135A-5P | 99.36 | 71.85 | 1601 |
| HSA-MIR-135B-5P | 99.36 | 71.63 | 1613 |
| HSA-MIR-4999-5P | 99.35 | 69.15 | 926 |
| HSA-MIR-20B-3P | 99.29 | 67.05 | 784 |
| HSA-MIR-4727-5P | 99.23 | 67.55 | 1154 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-26B-3P | 98.71 | 67.49 | 1102 |
| HSA-MIR-6731-3P | 98.61 | 67.86 | 749 |
| HSA-MIR-3668 | 98.52 | 68.76 | 951 |
| HSA-MIR-4317 | 98.49 | 67.09 | 987 |
| HSA-MIR-3976 | 96.67 | 67.79 | 1187 |
| HSA-MIR-376A-2-5P | 96.43 | 68.06 | 715 |
Literature-anchored findings (GeneRIF, showing 3)
- It found a single nucleotide polymorphism (SNP) located within the TAS2R13 gene, which showed a significant association with measures of alcohol consumption assessed via the Alcohol Use Disorders Identification Test (AUDIT). (PMID:22824251)
- Genetic variation in TRPV1 and TAS2Rs influence sensations from sampled EtOH and may potentially influence how individuals initially respond to alcoholic beverages. (PMID:25257701)
- Can cornelian cherry mask bitter taste of probiotic chocolate? Human TAS2R receptors and a sensory study with comprehensive characterisation of new functional product. (PMID:33556063)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tas2r102 | ENSMUSG00000056901 |
| mus_musculus | Tas2r124 | ENSMUSG00000060412 |
| mus_musculus | Tas2r121 | ENSMUSG00000071150 |
| rattus_norvegicus | Tas2r124 | ENSRNOG00000021430 |
| rattus_norvegicus | Tas2r102 | ENSRNOG00000030993 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 13 — Q9NYV9 (reviewed: Q9NYV9)
Alternative names: Taste receptor family B member 3
All UniProt accessions (1): Q9NYV9
UniProt curated annotations — full annotation on UniProt →
Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.
Subcellular location. Membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and palate epithelium and exclusively in gustducin-positive cells.
Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_076409* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (20 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NYV9-F1 | 87.96 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 162, 166
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 61 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS, GOBP_REGULATION_OF_CELL_DIVISION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, OCT1_B, GOBP_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_CELL_DIVISION
GO Biological Process (5): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), positive regulation of cytokinesis (GO:0032467), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), taste receptor activity (GO:0008527), bitter taste receptor activity (GO:0033038)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| detection of chemical stimulus involved in sensory perception of taste | 2 |
| transmembrane signaling receptor activity | 2 |
| sensory perception of bitter taste | 1 |
| cytokinesis | 1 |
| regulation of cytokinesis | 1 |
| positive regulation of cell division | 1 |
| positive regulation of cell cycle process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
340 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R13 | GNAT3 | A8MTJ3 | 842 |
| TAS2R13 | OR52L1 | Q8NGH7 | 622 |
| TAS2R13 | OR11H1 | Q8NG94 | 580 |
| TAS2R13 | OR4F4 | Q96R69 | 577 |
| TAS2R13 | OR1E1 | P30953 | 541 |
| TAS2R13 | OR2L13 | Q8N349 | 541 |
| TAS2R13 | OR2T33 | Q8NG76 | 528 |
| TAS2R13 | OR10G8 | Q8NGN5 | 520 |
| TAS2R13 | OR2T1 | O43869 | 513 |
| TAS2R13 | OR2D2 | Q9H210 | 506 |
| TAS2R13 | OR52H1 | Q8NGJ2 | 506 |
| TAS2R13 | OR2A4 | O95047 | 476 |
| TAS2R13 | TAS1R2 | Q8TE23 | 469 |
| TAS2R13 | OR2J3 | O76001 | 447 |
| TAS2R13 | VN1R4 | Q7Z5H5 | 417 |
IntAct
0 interactions, top by confidence:
BioGRID (2): CDC20 (Affinity Capture-Western), FZR1 (Affinity Capture-Western)
ESM2 similar proteins: P59528, P59530, Q5Y4Z2, Q645T9, Q645U9, Q645V1, Q645Y5, Q645Z3, Q645Z5, Q646A7, Q646B6, Q646B8, Q646C6, Q646D2, Q646D8, Q646D9, Q646F7, Q646G3, Q646G5, Q675B7, Q675B8, Q675B9, Q675C0, Q67ER8, Q67ES1, Q67ES5, Q67ES6, Q67ES9, Q67ET3, Q67ET5, Q7M707, Q7M711, Q7M712, Q7M713, Q7M715, Q7M717, Q7M718, Q7M720, Q7M725, Q7RTR8
Diamond homologs: P0DSN6, P0DTE0, P59528, P59530, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T0, Q645T2, Q645T3, Q645T4, Q645T6, Q645T7, Q645U8, Q645V1, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645V8, Q645V9, Q645Z2, Q645Z5, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
158 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:10908595:A:AC | donor_gain | 0.9900 |
| 12:10909368:T:TA | donor_gain | 0.9900 |
| 12:10908442:G:C | donor_gain | 0.9500 |
| 12:10909365:ACAT:A | donor_gain | 0.9500 |
| 12:10909366:CATC:C | donor_gain | 0.9500 |
| 12:10908437:A:C | donor_gain | 0.9400 |
| 12:10909362:T:C | donor_gain | 0.9200 |
| 12:10908681:C:CC | acceptor_gain | 0.9100 |
| 12:10908681:CTG:C | acceptor_loss | 0.9000 |
| 12:10908682:T:C | acceptor_loss | 0.9000 |
| 12:10909395:T:TA | donor_gain | 0.9000 |
| 12:10908676:TGTTT:T | acceptor_gain | 0.8400 |
| 12:10908679:TT:T | acceptor_gain | 0.8400 |
| 12:10909294:T:A | donor_gain | 0.8400 |
| 12:10908617:TATGG:T | donor_gain | 0.8000 |
| 12:10908618:ATGGA:A | donor_gain | 0.8000 |
| 12:10908621:G:T | donor_gain | 0.8000 |
| 12:10908619:T:C | donor_gain | 0.7900 |
| 12:10908678:TTT:T | acceptor_gain | 0.7900 |
| 12:10909350:T:C | donor_gain | 0.7800 |
| 12:10909369:C:A | donor_gain | 0.7800 |
| 12:10909367:A:C | donor_gain | 0.7600 |
| 12:10909367:AT:A | donor_gain | 0.7500 |
| 12:10908795:A:AC | donor_gain | 0.7300 |
| 12:10908796:C:CC | donor_gain | 0.7300 |
| 12:10908683:G:C | acceptor_loss | 0.7100 |
| 12:10908677:GTTT:G | acceptor_gain | 0.6500 |
| 12:10909108:A:AC | donor_gain | 0.6400 |
| 12:10909109:C:CC | donor_gain | 0.6400 |
| 12:10908441:AG:A | donor_gain | 0.6200 |
AlphaMissense
2006 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:10908942:A:C | F119L | 0.902 |
| 12:10908942:A:T | F119L | 0.902 |
| 12:10908944:A:G | F119L | 0.902 |
| 12:10908741:G:C | F186L | 0.870 |
| 12:10908741:G:T | F186L | 0.870 |
| 12:10908743:A:G | F186L | 0.870 |
| 12:10908987:G:C | S104R | 0.847 |
| 12:10908987:G:T | S104R | 0.847 |
| 12:10908989:T:G | S104R | 0.847 |
| 12:10909221:A:C | F26L | 0.832 |
| 12:10909221:A:T | F26L | 0.832 |
| 12:10909223:A:G | F26L | 0.832 |
| 12:10908957:G:C | F114L | 0.828 |
| 12:10908957:G:T | F114L | 0.828 |
| 12:10908959:A:G | F114L | 0.828 |
| 12:10908588:G:C | F237L | 0.807 |
| 12:10908588:G:T | F237L | 0.807 |
| 12:10908590:A:G | F237L | 0.807 |
| 12:10908570:A:C | S243R | 0.786 |
| 12:10908570:A:T | S243R | 0.786 |
| 12:10908572:T:G | S243R | 0.786 |
| 12:10908738:A:C | S187R | 0.783 |
| 12:10908738:A:T | S187R | 0.783 |
| 12:10908740:T:G | S187R | 0.783 |
| 12:10909121:A:G | W60R | 0.776 |
| 12:10909121:A:T | W60R | 0.776 |
| 12:10908726:A:C | F191L | 0.768 |
| 12:10908726:A:T | F191L | 0.768 |
| 12:10908728:A:G | F191L | 0.768 |
| 12:10909248:G:C | F17L | 0.760 |
dbSNP variants (sampled 300 via entrez): RS1001141532 (12:10908525 C>G), RS1001724816 (12:10911492 T>C), RS1001745876 (12:10911484 G>C), RS1002116116 (12:10907453 C>T), RS1003464289 (12:10910408 G>A,T), RS1003624566 (12:10910373 G>A), RS1003821563 (12:10910640 G>C), RS1004038128 (12:10907804 A>G), RS1004292612 (12:10910850 T>C,G), RS1005737601 (12:10909522 T>C), RS1007206506 (12:10911078 G>C,T), RS1007268362 (12:10910881 T>G), RS1007878217 (12:10908353 T>A,C), RS1007886475 (12:10910925 T>G), RS1007929043 (12:10907912 A>G)
Disease associations
OMIM: gene MIM:604792 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523471 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fluorene-9-bisphenol | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
ChEMBL screening assays
7 unique, capped per target: 7 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4346429 | Functional | Antagonist activity at recombinant human TAS2R13 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of oxyphenonium-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM d | Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Diphenidol